ASAM Supports Expansion of Access to Buprenorphine Through The Mainstreaming Addiction Treatment Act
ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…
NYSAM uses its voice and membership to promote public policies that advance addiction medicine and promote access to treatment.
July 30, 2019 by NYSAM
ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…
July 23, 2019 by Edwin Salsitz
Language Matters We have witnessed remarkable progress in the understanding of the disease of addiction over the past two decades.…
July 16, 2019 by NYSAM
NYSAM board members Dr. Melissa Weimer and Dr. Jeffrey Selzer together with Dr. Daniel Schatz, adjunct assistant professor in the…
January 15, 2019 by NYSAM
On June 11, 2018, the New York State Senate introduced Bill 8987 to amend the public health law in relation…
January 24, 2017 by NYSAM
Introduction Scientific evidence has firmly established that substance use disorders represent a chronic, relapsing disease requiring effective treatment with a…
June 22, 2016 by NYSAM
Strategies to Address the Heroin/Prescription Opioid Epidemic Traditional treatment for opioid addiction has a high failure rate unless the patient…